Fate’s approach to off-the-shelf cancer immunotherapy

Tuesday, February 7, 2017/in Auditoriet i forskningsbygget, Radiumhospitalet Event, Immuno-Oncology, Oslo Cancer Cluster /by oslocancer

Event Details

Date: Friday, February 17, 2017 10:15 am – 11:15 am
Venue: Auditoriet i forskningsbygget, Radiumhospitalet
Categories: Event, Immuno-Oncology, Oslo Cancer Cluster

Seminar of the KG Jebsen Center for Cancer Immunotherapy, co-hosted by Oslo Cancer Cluster

Speaker: Bob Valamehr, Vice President, Cancer Immunotherapy at Fate Therapeutics Inc

Moderator: Kalle Malmberg, KG Jebsen Center for Cancer Immunotherapy

Program will be available soon. Here is the invitation:

KG Jebsen Seminar_FEb 17th

Print This Post